在宫癌同步化疗和放射治疗期间,为吐而服用利尿剂:一个多中心回顾性研究
Naoya Tonomura1, Kensuke Yoshida2, Hajime Morita3
1Division of Hospital Pharmacy, Tokyo Metropolitan Tama Medical Center, Fuchu, Japan.
Anticancer research
|February 27, 2026
概括
在宫癌治疗期间,富罗塞米德可能比曼尼托尔更好的选择来预防化疗诱导的恶心和吐 (CINV). 在接受化疗放射治疗的患者中,与曼尼托尔相比,富罗塞米德与吐的频率较低和较晚发作有关.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 胃肠病学 胃肠病学
背景情况:
- 化疗诱导的恶心和吐 (CINV) 是宫癌并发化疗放射治疗 (CCRT) 的重大挑战.
- 曼尼托和富罗塞米德用于治疗西斯胺诱导的毒性,但它们对CINV的比较作用尚不清楚.
研究的目的:
- 评价曼尼托尔与富罗塞米德对接受CCRT的宫癌患者吐的发生率和时间的影响.
主要方法:
- 这是一项多中心的回顾性研究,涉及485名每周接受基于西斯的CCRT治疗的患者.
- 在接受曼尼托尔 (n=206) 和富洛塞米德 (n=279) 的患者之间对CINV结局的比较.
主要成果:
- 在曼尼托尔组 (18.4%) 出现吐的频率高于罗胺组 (10.4%).
- 时间到事件分析表明,在CCRT期间,吐与曼尼托尔的早期发作.
结论:
- 富洛塞米德可能比曼尼托尔更适合于治疗宫癌患者进行CCRT的CINV风险管理的选择.
- 这些发现可能与曼尼托的透性和CCRT诱导的肠道透性变化有关.
相关概念视频
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
744
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
744
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
691
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
691
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
983
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
983
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
864
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
864
Imaging Studies for Cardiovascular System V: CT
448
Cardiac computed tomography (CT) scanning is an advanced cardiac imaging technique that utilizes CT technology, with or without intravenous (IV) contrast, to produce accurate cross-sectional virtual slices of specific areas of the heart, coronary circulation, and major blood vessels such as the aorta, pulmonary veins, and arteries. The computer processes these slices to generate three-dimensional images. Multidetector CT (MDCT) is a rapid form of CT scanning that captures multiple slices...
448
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
315
Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
315


